Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

AMA resolution backs expanded low-dose CT screenings for lung cancer, heart risk
Dana Smetherman, MD, CEO of the American College of Radiology, discusses the policy, which urges for more robust promotion of low-dose CT as a public health tool.
Symptom-detected breast cancers more likely to require mastectomy, chemotherapy
New research adds to the “strong evidence” supporting screening guidelines and highlights the importance of women adhering to clinical recommendations.
ACC backs AMA resolution to boost lung cancer and heart disease screenings in smokers with low-dose CT scans
Former American College of Cardiology president Kim Allan Williams, Sr., MD, an ACC delegate to the American Medical Association House of Delegates, discusses an AMA resolution aimed at improving public awareness of low-dose CT lung cancer exams that can screen for coronary artery calcium at the same time.
Symptom-detected breast cancers nearly 7 times more likely to be diagnosed at advanced stage
Advances in treatment are often credited with improving breast cancer outcomes, but new findings suggest the decrease in mortality may actually be due to improved screening initiatives.
Should more imaging be included in physicals?
John Simon, MD, CEO of SimonMed Imaging, says imaging has considerably advanced for noninvasive detection of disease and it may be time for it to play a greater role in annual physicals, especially in executive physical exams.

Routine abdominal CTs offer insight into cardiovascular risk

During this year's RSNA meeting, providers were especially interested in how AI applications could enhance opportunistic screening capabilities.

Screening efforts have helped avert millions of cancer-related deaths in recent decades

In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.

Example of the four types of breast tissue density. The density of fibroglandular tissue inside the breast impacts the ability to easily see cancers. Cancers are very easy to spot in fatty breasts, but are almost impossible to find in extremely dense breasts. These examples show craniocaudal mammogram findings characterized as almost entirely fatty (far left), scattered areas of fibroglandular density (second from left), heterogeneously dense (second from right), and extremely dense (far right). RSNA

What breast density status can tell us about cardiovascular risk

Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.

HeartLung Technologies, a Houston-based artificial intelligence (AI) company, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for new software that assesses chest CT scans for signs of coronary artery disease (CAD) and other potentially fatal heart conditions. The newly cleared offering, AutoChamber, was designed with opportunistic heart evaluations in mind.

FDA clears AI tool that flags signs of heart disease in chest CT scans

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.

Patients without PCPs struggle to access lung cancer screening, despite eligibility

It is estimated that up to one-third of the U.S. population does not have a primary care provider.

Breast cancer rates among women in their 30s are on the rise

Screening uptake for younger women has been steadily rising for years. Consequently, so have cancer rates among the population.

Radiologist Dana Ataya, MD, writes song to clear up confusion on breast cancer screening recs.

Singing radiologist pens song to clear up confusion about breast cancer screening recs

Dana Ataya, MD, is backed by Moffitt Cancer Center's band, The ReMissions.

MedCognetics CogNet AI-MT technology is the first embedded AI cancer detection system built into the mammography system to eliminate eliminates latency and delivering immediate, high-quality image analysis and can help prioritize exams in the worklist

AI loaded onto mammography systems can flag possible cancers in real time to speed workflows

A new AI solution offers complete mammography analysis on the imaging system, in the radiology workflow, to reduce the wait time for results.

Screening

AMA resolution backs expanded low-dose CT screenings for lung cancer, heart risk

Symptom-detected breast cancers more likely to require mastectomy, chemotherapy

ACC backs AMA resolution to boost lung cancer and heart disease screenings in smokers with low-dose CT scans

Symptom-detected breast cancers nearly 7 times more likely to be diagnosed at advanced stage

Should more imaging be included in physicals?